Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and ...

Investing.com — Processa Pharmaceuticals Inc. (PCSA)股价已跌至52周低点，触及0.22美元。这一显著下跌反映了公司正经历艰难时期，该股票一年内下跌了85.8%。根据 InvestingPro 数据显示，公司市值已萎缩至仅124万美元，而技术指标表明该股票处于超卖区域。投资者目睹了公司市值在过去一年中的急剧下降，因为该股票在市场压力和行业特定逆风中 ...

Processa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings ...

HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next ...

Processa Pharmaceuticals (NASDAQ:PCSA – Get Free Report) last posted its quarterly earnings data on Thursday, March 20th. The company reported ($0.74) EPS for the quarter, beating analysts ...